Chris Martin is currently the Director of Medical Writing at Autolus Therapeutics, a position held since 2024. Previously, Chris served as a Senior Manager of Medical Writing at Gilead Sciences from 2020 to 2023 and held various roles in medical writing including Director and Contract Medical Writer at Chris Martin Medical Writing Ltd from 2018 to 2020. Earlier in their career, Chris worked at organizations such as Celgene, Amgen, and Covance, contributing in various managerial and senior writing roles. Chris earned a PhD from the University of St. Andrews, where education took place from 1999 to 2003, and also worked as a Medical Research Council Post-doctoral Research Associate at King's College London.
This person is not in the org chart
This person is not in any teams
This person is not in any offices